Sana Biotechnology, Inc. (SANA)

Sana Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	103.36	127.57	133.52	176.77	253.03	124.81
Short-Term Investments	49.7	24.93	71.68	247.2	297.97	253.46
Cash & Short-Term Investments	153.05	152.5	205.2	423.96	551	378.26
Cash Growth	-23.09%	-25.68%	-51.60%	-23.05%	45.66%	172.17%
Prepaid Expenses	4.51	4.48	4.49	14.37	7.11	6.2
Restricted Cash	4.2	3.83	3.83	6.1	-	-
Total Current Assets	161.76	160.81	213.52	444.44	558.1	384.47
Property, Plant & Equipment	70.64	135.27	145.59	159.4	161.78	109.94
Long-Term Investments	-	-	-	10.05	195.88	33.73
Goodwill	140.63	140.63	140.63	140.63	140.63	140.63
Other Intangible Assets	59.2	59.2	59.2	59.2	59.2	59.2
Other Long-Term Assets	3.22	5.12	6.37	9.01	13.82	2.33
Total Assets	435.43	501.02	565.3	822.72	1,129	730.3
Accounts Payable	1.86	5.21	4.11	2.86	2.22	2.25
Accrued Expenses	18.89	27.39	37.98	39.12	28.91	22.59
Current Portion of Leases	14.77	12.83	13.2	12.39	9.16	3.71
Other Current Liabilities	-	-	9.2	57.14	58.95	2.89
Total Current Liabilities	35.51	45.43	64.49	111.5	99.24	31.45
Long-Term Leases	74.97	89.06	90.9	95.86	101.78	68.2
Other Long-Term Liabilities	129.64	116.02	122.41	116.04	199.89	198.94
Total Liabilities	240.12	250.52	277.79	323.41	400.91	298.58
Common Stock	0.03	0.02	0.02	0.02	0.02	0
Additional Paid-In Capital	1,985	1,855	1,626	1,558	1,515	8.22
Retained Earnings	-1,790	-1,605	-1,338	-1,055	-785.36	-429.43
Comprehensive Income & Other	0.02	0.01	-0.06	-4.33	-1.37	0.03
Total Common Equity	195.31	250.5	287.51	499.32	728.5	-421.18
Shareholders' Equity	195.31	250.5	287.51	499.32	728.5	431.71
Total Liabilities & Equity	435.43	501.02	565.3	822.72	1,129	730.3
Total Debt	89.74	101.9	104.1	108.25	110.94	71.91
Net Cash (Debt)	63.32	50.6	101.1	325.76	635.93	340.09
Net Cash Growth	-38.48%	-49.95%	-68.97%	-48.77%	86.99%	272.57%
Net Cash Per Share	0.26	0.22	0.52	1.73	3.82	26.13
Filing Date Shares Outstanding	266.37	225.02	220.45	191.35	185.18	177.43
Total Common Shares Outstanding	262.26	223.92	197.86	191.02	184.93	16.17
Working Capital	126.25	115.38	149.03	332.93	458.87	353.02
Book Value Per Share	0.74	1.12	1.45	2.61	3.94	-26.05
Tangible Book Value	-4.51	50.68	87.68	299.49	528.68	-621.01
Tangible Book Value Per Share	-0.02	0.23	0.44	1.57	2.86	-38.40
Machinery	44.71	57.79	54.77	64.76	49	30.59
Construction In Progress	-	40.34	26.33	1.71	1.39	8.32
Leasehold Improvements	39.06	33.34	31.36	34.43	33.85	15.6

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q